About This Digest

What Iron Peptide Innovations is

Iron Peptide Innovations is an independent editorial digest covering the published research on two peptides studied for recovery and tissue repair: BPC-157 and TB-500, with TB-500 as the lead. The site exists to make a scattered and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches.

The organizing idea is complementarity: BPC-157 and TB-500 approach repair from different directions — blood-vessel growth and cell migration — so reading them together gives a fuller picture than either alone. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every source across both.

How it is compiled

Three principles govern what appears on this site.

First, everything is anchored to the peer-reviewed literature. Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed links — collected on the references page. Where a finding comes from a review rather than a primary study, the review is cited as such.

Second, the evidence is reported at its true strength. Doses are described as studied — for example, "studied at 2 mg/kg in rats" — never scaled to humans or offered as a recommendation. Where evidence is preclinical, single-lab, or rests on a parent molecule rather than the marketed compound, the page says so plainly. That candor is the point, not an afterthought.

Third, the two pages are cross-referenced. Because themes — angiogenesis, actin and migration — recur across both compounds, the pages link to one another and to the comparison page so a reader can follow a mechanism from one peptide to the next.

What it is not

Iron Peptide Innovations is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical, and it has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person, and it never frames an animal-study dose as something a human should take.

The peptides discussed here are research compounds. Neither is an approved medicine; both are explicitly prohibited in sport. Readers interested in any condition described in the underlying research should consult a licensed clinician working with regulated, evidence-based options. The value this site offers is a plain, accurate map of the literature — nothing more, and nothing it pretends to be.